ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.350
-0.530 (-10.86%)
At close: Mar 12, 2026, 4:00 PM EDT
4.400
+0.050 (1.15%)
After-hours: Mar 12, 2026, 7:32 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $552.64 million as of March 12, 2026. Its market cap has increased by 252.82% in one year.
Market Cap
552.64M
Enterprise Value
730.85M
1-Year Change
252.82%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $552.64M, a decrease of -72.95%. That is a compound annual growth rate of -20.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 552.64M | 26.38% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 595.09M |
| Vor Biopharma | 583.35M |
| Allogene Therapeutics | 555.08M |
| Vanda Pharmaceuticals | 549.11M |
| Immix Biopharma | 534.33M |
| Rocket Pharmaceuticals | 534.16M |
| Neumora Therapeutics | 533.61M |
| YD Bio | 528.10M |